Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077350
Status:
COMPLETED
Last Update Posted:
2013-02-27
First Post:
2004-02-10
Brief Title:
A Phase II Trial of Triapine NSC 663249 in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer
Sponsor:
Organization:
National Cancer Institute NCI